18eatfi presentation1.ppt 2
TRANSCRIPT
![Page 1: 18eaTFI Presentation1.Ppt 2](https://reader033.vdocuments.mx/reader033/viewer/2022051311/544a93d6af79596c4d8b48f9/html5/thumbnails/1.jpg)
1
ww
w.t
fi-l
td.c
o.u
k
Micro & Nanotechnology transforming the Market in
Medical Applications
Dr J Malcolm Wilkinson
Technology For Industry Ltd
Cambridgeshire, UK
www.tfi-ltd.co.uk
![Page 2: 18eaTFI Presentation1.Ppt 2](https://reader033.vdocuments.mx/reader033/viewer/2022051311/544a93d6af79596c4d8b48f9/html5/thumbnails/2.jpg)
2
ww
w.t
fi-l
td.c
o.u
k
Technology For Industry
Bridging the gap between industry and revolutionary technologyfrom academia and research institutes
![Page 3: 18eaTFI Presentation1.Ppt 2](https://reader033.vdocuments.mx/reader033/viewer/2022051311/544a93d6af79596c4d8b48f9/html5/thumbnails/3.jpg)
3
ww
w.t
fi-l
td.c
o.u
k
TFI provide solutions for industry leaders to address their greatest technology challenges and achieve long term growth
• TFI is the market leader in the medical Micro and Nanotechnology consultancy sector
• Unrivalled team of experts
• Independent and effective
• Produce tailored solutions not ‘one size fits all’
![Page 4: 18eaTFI Presentation1.Ppt 2](https://reader033.vdocuments.mx/reader033/viewer/2022051311/544a93d6af79596c4d8b48f9/html5/thumbnails/4.jpg)
4
ww
w.t
fi-l
td.c
o.u
k
Contents of Presentation
Overview of the Market & Market Drivers Technology Push – Hot R&D Topics Drug Discovery Drug Delivery Monitoring & Diagnosis Implanted Devices
![Page 5: 18eaTFI Presentation1.Ppt 2](https://reader033.vdocuments.mx/reader033/viewer/2022051311/544a93d6af79596c4d8b48f9/html5/thumbnails/5.jpg)
5
ww
w.t
fi-l
td.c
o.u
k
Present Major Medical Applications of MNT
- Cardiovascular- Drug delivery &
Therapy- Genetics- Neurology- Oncology
- Point of care diagnostics
- Surgery- Tissue engineering - Prostheses- Pathology
….but what are the largest or fastest growing markets?
![Page 6: 18eaTFI Presentation1.Ppt 2](https://reader033.vdocuments.mx/reader033/viewer/2022051311/544a93d6af79596c4d8b48f9/html5/thumbnails/6.jpg)
6
ww
w.t
fi-l
td.c
o.u
k
Size of Markets
Drugs & Drug Delivery $80 billion
Blood Analysis $22 billion
Heart Pacemakers & Other Implants $16 billion
Endoscopy & MIS Tools $5 billion Hearing Aids $4 billion DNA / Lab on Chip $1.2 billion….and the MNT based Products account for $7 billion
or at the component level about $363 million
![Page 7: 18eaTFI Presentation1.Ppt 2](https://reader033.vdocuments.mx/reader033/viewer/2022051311/544a93d6af79596c4d8b48f9/html5/thumbnails/7.jpg)
7
ww
w.t
fi-l
td.c
o.u
k
Drivers in healthcare
• Ageing population • Personalized health • Earlier diagnosis • Cost of healthcare• Global travel (epidemics) • Food safety • Monitoring of individuals (glucose, cholesterol)• Ethics (eg stem cell research, animal testing)
![Page 8: 18eaTFI Presentation1.Ppt 2](https://reader033.vdocuments.mx/reader033/viewer/2022051311/544a93d6af79596c4d8b48f9/html5/thumbnails/8.jpg)
8
ww
w.t
fi-l
td.c
o.u
k
Hot R&D Topics
Lab on Chip Retinal Implants Non Invasive Blood Glucose Monitoring The ‘Electronic Rat’
…but what are realistic timescales?
![Page 9: 18eaTFI Presentation1.Ppt 2](https://reader033.vdocuments.mx/reader033/viewer/2022051311/544a93d6af79596c4d8b48f9/html5/thumbnails/9.jpg)
9
ww
w.t
fi-l
td.c
o.u
k
Timescales?
Roadmaps based on • current status of R&D
• Future vision
• Past experience Balance market drivers against barriers
![Page 10: 18eaTFI Presentation1.Ppt 2](https://reader033.vdocuments.mx/reader033/viewer/2022051311/544a93d6af79596c4d8b48f9/html5/thumbnails/10.jpg)
10
ww
w.t
fi-l
td.c
o.u
k
Drug Discovery & Development
![Page 11: 18eaTFI Presentation1.Ppt 2](https://reader033.vdocuments.mx/reader033/viewer/2022051311/544a93d6af79596c4d8b48f9/html5/thumbnails/11.jpg)
11
ww
w.t
fi-l
td.c
o.u
k
Drug Discovery & Development Process
© Dr George Adamson
2 4 6 8 10 12 14 16 18 20
Discovery & Preclinical
Phase I Phase II Phase III FDA
Market New DrugManufacturing Development
(Phase IV)
Discovery: 5-10000 drugsPreclinical: 250 drugs
Clinical Trials: 5 drugsFDA Market Approval: 1 drug
32.5% 5.6% 10.6% 15.1% 7.8% 11.1%% of research & development costs (17.4% uncategorized)
Marketing costsSales revenues
Years 0 2 4 6 8 10 12 14 16 18
![Page 12: 18eaTFI Presentation1.Ppt 2](https://reader033.vdocuments.mx/reader033/viewer/2022051311/544a93d6af79596c4d8b48f9/html5/thumbnails/12.jpg)
12
ww
w.t
fi-l
td.c
o.u
k
Drug Discovery & Development
Issues How to speed up the process Faster removal of poor candidates from the pipeline Reducing screening costs Reducing the need for animal testing
Potential for Micro & Nanotechnology Massively parallel screening Automation of the process Building the ‘electronic rat’
![Page 13: 18eaTFI Presentation1.Ppt 2](https://reader033.vdocuments.mx/reader033/viewer/2022051311/544a93d6af79596c4d8b48f9/html5/thumbnails/13.jpg)
13
ww
w.t
fi-l
td.c
o.u
k
Drug Discovery & Development
Caliper DNA Chip
Infineon DNA Chip
Multi - Chamber BioReactor
![Page 14: 18eaTFI Presentation1.Ppt 2](https://reader033.vdocuments.mx/reader033/viewer/2022051311/544a93d6af79596c4d8b48f9/html5/thumbnails/14.jpg)
14
ww
w.t
fi-l
td.c
o.u
k
Roadmap of MNT in Drug Development
Years to Market
0 5 10 25+2015
Persistent optical tags
e.g. q-dots
In-Vivo reporter imaging (later for human use)
High content screening
e.g. multiplexing reporter agents
Holistic analysis of cellular function (e.g.
comparative genomics/proteomics using micro & nanotechnology)
Increasingly smart tags
Proteomics chips with increasing functionality
DNA nanoarrays e.g. dip pen lithography
Nanopore DNA sequencing
Microfluidics => Nanofluidics
MEMS integration for true lab-on-a-chip
Full SNP analysis (and interpretation?)
Improved understanding of links between genes and disease
Improved understanding of drug activity and toxicity
![Page 15: 18eaTFI Presentation1.Ppt 2](https://reader033.vdocuments.mx/reader033/viewer/2022051311/544a93d6af79596c4d8b48f9/html5/thumbnails/15.jpg)
15
ww
w.t
fi-l
td.c
o.u
k
Blood Glucose Monitoring
Source: GlucowatchSource: Lein Applied diagnostics
Fingerstick
Invasive Minimally Invasive Non Invasive
![Page 16: 18eaTFI Presentation1.Ppt 2](https://reader033.vdocuments.mx/reader033/viewer/2022051311/544a93d6af79596c4d8b48f9/html5/thumbnails/16.jpg)
16
ww
w.t
fi-l
td.c
o.u
k Blood Glucose Monitoring
0 2 4 6 8 10 12 14 16 18 20 22 Years
Implantable Sensors
3 Day Real-time data Longer duration 30d - 12m
Finger Prick Systems
Design & alternative site testing
Permanent Implantabe Sensor
Iontophoresis
(Glucowatch)
Laser Poration
Ultrasound Poration
Microneedle Poration
EXISTING
INVASIVE
MINIMALLY INVASIVE
Electromagnetic Electrolyte Detection
complementary replacement to blood test
NIR Sensor
Initial Improved signal processing
MIR Sensor
Polarimetric Sensor
Retinal Spectroscopy
Photoacoustic
Terahertz Sensor?
NON INVASIVE
Magnetowave Sensor?
Widely Available Cure for Type I
Diabetes
Time to Market from 2005
Fluorescent Glucose Selective Gels
Catheter based Implantable
Healthy Living Culture to Reduce Obesity and Type II Diabetes
![Page 17: 18eaTFI Presentation1.Ppt 2](https://reader033.vdocuments.mx/reader033/viewer/2022051311/544a93d6af79596c4d8b48f9/html5/thumbnails/17.jpg)
17
ww
w.t
fi-l
td.c
o.u
k
Drug Delivery
MICROPARTS
KTH
ALZA CORP
Micronozzle in nebuliser, Microparts
Microneedles development, KTH
Stealth technology, lipid nanoparticle, Alza Corp.
![Page 18: 18eaTFI Presentation1.Ppt 2](https://reader033.vdocuments.mx/reader033/viewer/2022051311/544a93d6af79596c4d8b48f9/html5/thumbnails/18.jpg)
18
ww
w.t
fi-l
td.c
o.u
kDrug Delivery Roadmap for MNT
0 2 4 6 8 10 12 14 16 18 20 22 Years
Inhaler Nanopowders
Oral Nanotechnologies (hydrogels, dendrimers, liposomes etc.)Peptide drugs Proteins + Sustained release
Tablet Coatings
Virus Vector Directed Delivery
Nanotechnology Based Directed Delivery (e.g. dendrimers, microencapsulation)
Oral/Nasal Sprays
External Infusion Pumps
Transdermal: chemical modifiers
Inhaler Delivery Devices:
CFC free Ease of use Deep lung Variable dose
Needle-less Injectors
Transdermal Iontophoresis
Transdermal Microneedles
Implantable Infusion Pumps
Closed Loop Systems:
External Internal
Transdermal Ultrasound
Implantable Release Reservoirs
Time to Market from 2005
![Page 19: 18eaTFI Presentation1.Ppt 2](https://reader033.vdocuments.mx/reader033/viewer/2022051311/544a93d6af79596c4d8b48f9/html5/thumbnails/19.jpg)
19
ww
w.t
fi-l
td.c
o.u
k
Implanted Devices
pacemakers stents
![Page 20: 18eaTFI Presentation1.Ppt 2](https://reader033.vdocuments.mx/reader033/viewer/2022051311/544a93d6af79596c4d8b48f9/html5/thumbnails/20.jpg)
20
ww
w.t
fi-l
td.c
o.u
k
Implanted Devices
Installed base of Implants Worldwide
1960 1970 1980 1990 2000
1
10
100
1K
10K
100K
1M
10M
Heart Pacemaker
Bladder Implant Cochlear Implant
Cancer Pain
Epilepsy
Spine
…but cardiovascular stents do not fit this model
![Page 21: 18eaTFI Presentation1.Ppt 2](https://reader033.vdocuments.mx/reader033/viewer/2022051311/544a93d6af79596c4d8b48f9/html5/thumbnails/21.jpg)
© MANCEF or the individual authors
TodayToday Start feeling sick Get a Doctor’s appointment and wait
or go to the ER (and wait) One treatment fits all
![Page 22: 18eaTFI Presentation1.Ppt 2](https://reader033.vdocuments.mx/reader033/viewer/2022051311/544a93d6af79596c4d8b48f9/html5/thumbnails/22.jpg)
© MANCEF or the individual authors
From Housecalls to House CallsFrom Housecalls to House Calls
Tomorrow, your house will call
the doctor
![Page 23: 18eaTFI Presentation1.Ppt 2](https://reader033.vdocuments.mx/reader033/viewer/2022051311/544a93d6af79596c4d8b48f9/html5/thumbnails/23.jpg)
© MANCEF or the individual authors
![Page 24: 18eaTFI Presentation1.Ppt 2](https://reader033.vdocuments.mx/reader033/viewer/2022051311/544a93d6af79596c4d8b48f9/html5/thumbnails/24.jpg)
24
ww
w.t
fi-l
td.c
o.u
k
TFI Roadmaps
Further Roadmaps, Market Analysis and Technology Trends will be available within next few months. Check www.tfi-ltd.co.uk for further details.
TFI ~ Navigating The Nanospace ©